Evidence map›Paper›PMID 39266564›Full record

ArticleNature communications2024

Context-aware single-cell multiomics approach identifies cell-type-specific lung cancer susceptibility genes.

Erping Long, Jinhu Yin, Ju Hye Shin, Yuyan Li, Bolun Li, Alexander Kane, Harsh Patel, Xinti Sun, Cong Wang, Thong Luong and 15 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Prioritizing context-specific genetic risk mechanisms in 11 solid cancers.medRxiv : the preprint server for health sciences · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Erping Long *Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-3502-5596
Jinhu Yin *Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0009-0000-3153-4126
Ju Hye Shin *Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Yuyan Li *Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bolun LiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Alexander KaneDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Harsh PatelDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-9860-8254
Xinti SunInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-4264-9567
Cong WangInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Thong LuongDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Jun XiaDepartment of Biomedical Sciences, Creighton University, Omaha, NE, USA.
Younghun HanInstitute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-5048-8479
Jinyoung ByunInstitute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-8579-1435
Tongwu ZhangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0003-2124-2706
Wei ZhaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0001-5103-3871
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0003-4507-329X
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Qing LanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-0888-8839
Yoon Soo ChangDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-3340-4223
Fulong YuGuangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China.
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-8540-7023
Jianxin ShiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0001-8606-4707
Jin Gu LeeDepartment of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea. CSJGLEE@yuhs.ac.
Eun Young KimDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. narae97@yuhs.ac.
Jiyeon ChoiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. jiyeon.choi2@nih.gov.ORCID 0000-0002-0955-2384

Funding

Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos, Rayjean J. Hung · 2017 to 2026
$23.7M
Sequencing Familial Lung CancerR01CA243483 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos, DIPTASRI M MANDAL · 2023 to 2026
$4.2M
The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and MutagenesisR00ES033259 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI XIA, JUN · 2022 to 2024
$731k
Heterogeneous Genetic Architecture in Lung Cancer RiskR03CA277197 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BYUN, JINYOUNG · 2024 to 2025
$156k
Chinese Academy of Medical Sciences (CAMS) 2023-I2M-3-010National Natural Science Foundation of China (National Science Foundation of China) 82090011National Natural Science Foundation of China (National Science Foundation of China) Excellent Youth Scholars ProgramNational Research Foundation of Korea (NRF) No. 2023R1A2C1004922NCI NIH HHS R01 CA243483NCI NIH HHS R03 CA277197NCI NIH HHS U19 CA203654NIEHS NIH HHS R00 ES033259U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) R00ES033259
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) identified over fifty loci associated with lung cancer risk. However, underlying mechanisms and target genes are largely unknown, as most risk-associated variants might regulate gene expression in a context-specific manner. Here, we generate a barcode-shared transcriptome and chromatin accessibility map of 117,911 human lung cells from age/sex-matched ever- and never-smokers to profile context-specific gene regulation. Identified candidate cis-regulatory elements (cCREs) are largely cell type-specific, with 37% detected in one cell type. Colocalization of lung cancer candidate causal variants (CCVs) with these cCREs combined with transcription factor footprinting prioritize the variants for 68% of the GWAS loci. CCV-colocalization and trait relevance score indicate that epithelial and immune cell categories, including rare cell types, contribute to lung cancer susceptibility the most. A multi-level cCRE-gene linking system identifies candidate susceptibility genes from 57% of the loci, where most loci display cell-category-specific target genes, suggesting context-specific susceptibility gene function.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyLung NeoplasmsSingle-Cell AnalysisChromatinFemaleGene Expression Regulation, NeoplasticHumansMaleMultiomicsPolymorphism, Single NucleotideQuantitative Trait LociRegulatory Sequences, Nucleic AcidTranscriptomeChromatin

Identifiers

PMID39266564
PMCPMC11392933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.